Cancer Treatment and Research Communications
Издатель: Elsevier · ISSN 2468-2942 · 85 статей
- Epigenetic profiling of neuroactive curcumin on histone signatures in breast cancer using gen3DNet
- Comparative cytotoxic, apoptotic, cell-cycle, gene-expression, and antioxidant effects of lutein and cabbage extract in AGS gastric cancer cells
- Proportion, histopathological spectrum, and clinicopathological characteristics of soft tissue sarcomas in Cameroon: A sixteen-year retrospective registry-based study
- Association between perioperative six-minute walk distance and postoperative recurrence and survival in patients with lung cancer
- Assessment of expression of EGFR-related lncRNAs in colorectal cancer
- Background parenchymal enhancement on contrast-enhanced mammography: A critical review of measurement, determinants, and cancer associations
- From Tests to Benefits: Identifying Patients Who Benefit from MammaPrint Testing in Early-Stage Breast Cancer
- Nationwide patterns in the treatment of recurrent glioblastoma: a survey among German neurosurgeons, radiation-oncologists, and neuro-oncologists
- Compartment‑specific tumor-core CD8+ and FOXP3+ T cells provide exploratory prognostic stratification after curative resection of hepatocellular carcinoma
- Efficacy and safety of cetuximab or capecitabine monotherapy as maintenance therapy in RAS/BRAF Wild-type metastatic colorectal cancer: a retrospective study
- Hypoxia imaging as a radiomics signature in tumors using novel 19F-Eu-based contrast agents for magnetic resonance imaging
- miR-221 and miR-222 in pancreatic ductal adenocarcinoma: mechanistic evidence, extracellular vesicle communication, biomarker candidates, and therapeutic prospects
- Beyond viral positivity: Molecular biomarkers for etiologic stratification of virus-associated and nonviral cancers
- Corrigendum to ’Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study’ [Cancer Treat Res Commun. 2026:47:101143]
- Corrigendum to Tumor-microbe transkingdom interactions in cancers at body interfaces: mechanisms of neutrophil lifespan extension and functional reprogramming with therapeutic implications [Cancer Treatment and Research Communications 46 (2026) 101065]
- Beyond the flask: cancer cell lines and the limits of biological extrapolation
- Camrelizumab combined with platinum-free single-agent chemotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a prospective, single-arm, exploratory study
- Metformin Use and All-Cause and Cause-Specific Mortality in Patients with Kidney Cancer: A Nationwide Korean Cohort Study
- Engineered Mesenchymal Stromal Cells for Solid Tumours: Integrating Bibliometric Landscape Analysis with Preclinical Meta-Analysis of Efficacy
- A lightweight attention-aided CNN model with multi-level feature fusion for breast cancer classification using histopathological images
- CAPN6 Is Upregulated in Trastuzumab-Resistant HER2-Positive Breast Cancer Cells and Modulates Rac1/PAK1-Related Signaling and T-DM1 Response
- Current Status of Olaparib Treatment Based on the Japanese Electronic Medical Record Database
- Single-Cell and Spatial Transcriptomic Dissection of Tumor-Associated Macrophage Heterogeneity in Cervical Cancer: Multi-Omics Perspectives and Immunotherapy Resistance
- L-Asparaginase Exposure and Immune Fitness in Pediatric Acute Lymphoblastic Leukemia: A Critical Evidence Appraisal for Immunotherapy Integration
- Clinical and economic impact model of blood-based biomarkers in cancer risk assessment of pulmonary nodules (PNs) from a health-system perspective